Some key achievements include the development of targeted drug delivery systems that significantly reduce adverse effects, nanoscale imaging agents that enhance the detection of tumors, and nanoparticle-based vaccines that stimulate the immune system to fight cancer. These advancements have shown promising results in preclinical studies and are progressing toward clinical trials.
